Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Nov 2, 2015
Record Revenue of $15.7 Million Driven by Strong Consumables Demand Expanded Solutions in Precision Oncology, including nCounter SPRINT and 3D Biology, Strengthen Company's Position at Center of Cancer Ecosystem SEATTLE, Nov. 2, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools f...
Oct 12, 2015
SEATTLE, Oct. 12, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company will release third quarter 2015 financial results after the close of trading on Monday, November 2, 2015. Company management will host...
Sep 11, 2015
NEW YORK, Sept. 11, 2015 (GLOBE NEWSWIRE) -- At a meeting with analysts and investors today, members of the senior management team of NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, plan to unveil the company's strategic roadmap to drive continued growth and...
Sep 10, 2015
SEATTLE, Sept. 10, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the commercial launch of the nCounter® RNA:Protein PanCancer Immune Profiling Panel. The panel can be analyzed on the full line of nCounter Analy...
Sep 9, 2015
SEATTLE, Sept. 9, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced that the PAM50 gene signature, commercialized as the Prosigna® Breast Cancer Gene Signature Assay, has been added to the European Society for Medi...
Aug 27, 2015
SEATTLE, Aug. 27, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it will host a meeting for analysts and institutional investors on Friday, September 11, 2015, in New York City from 8:00 a.m. to approximately 10...
Aug 26, 2015
SEATTLE, Aug. 26, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that Brad Gray, President and Chief Executive Officer, is scheduled to present at two upcoming investor conferences: The 2015 Baird Healt...
Aug 13, 2015
SEATTLE, Aug. 13, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses molecular diagnostic technologies through its MolDx program, has issued a f...
Aug 4, 2015
Cancer Focus and Leadership in Immuno-Oncology Strengthened by Collaboration with Merck Launch of nCounter SPRINT Broadens Reach in Cancer Research Market SEATTLE, Aug. 4, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic produc...
Jul 30, 2015
SEATTLE, July 30, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that its management is scheduled to present at the Canaccord Genuity Growth Conference in Boston. Brad Gray, President and Chief Executive Offi...
Jul 21, 2015
SEATTLE, July 21, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company will release second quarter 2015 financial results after the close of trading on Tuesday, August 4, 2015. Company management will host...
Jul 16, 2015
SEATTLE, July 16, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced that the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology for breast cancer have been updated to acknowledge that ...
Jul 15, 2015
Expanded nCounter® Instrument Product Line Expected to Reach Deeper Into Cancer Research Market SEATTLE, July 15, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the expansion of the nCounter Analysis Sys...
Jul 8, 2015
SEATTLE, July 8, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that Alessandra Cesano, M.D., Ph.D. has been named Chief Medical Officer, effective July 6, 2015. Dr. Cesano brings more than 25 years of experi...
Jul 7, 2015
SEATTLE, July 7, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the publication of a study online in Clinical Cancer Research that reinforces the ability of the company's Prosigna® Breast Cancer Assay to inform ...
Page: First Previous
...
...
Next Last
 
= add release to Briefcase